|
15
обмен опЫтом
ноина. автореф. дисс. к.м.н. – москва. 2005.
22 с.
14. Рагимова з.Э. современные подходы к лече-
нию клинических проявлений гиперандроге-
нии. автореф. дисс. к.м.н. – москва. 2008.
15. скрипкин Ю.к. кожные и венерические болез-
ни. – м.: триада-фарм. 2005.
16. суворова к.н., котова н.в. акне // новый ме-
дицинский журнал. 2006. № 3. с. 7–10.
17. abdel Fattah n.S., Shaheen m.a., Ebrahim a.a.
Tissue and blood superoxide dismutase activities
and malondialdehyde levels in different clinical
severities of acne vulgaris // Br j Dermatol.
2008. Vol. 159 (5): P. 1086–1091.
18. Bergler Czop B. Hormonal factors in etiology of
common acne // Pol-merkuriusz-lek. 2004. Vol.
16. № 95. P. 490–492.
19. Blouin K., richard C., Belanger C. et al. local
androgen inactivation in abdominal visceral
adipose tissue // j Clin Endocrinol metab. 2003.
Vol. 88(12). P. 5944–5950.
20. Carmina E., lobo r.a. a comparison of the
relative efficacy of antiandrogens for the treatment
of acne in hyperandrogenic women // Clin
Endocrinol (Oxf). 2002. Vol. 57(2). P. 231–234.
21. Deugarte C.m., Bartolucci a.a., azziz r.
Prevalence of insulin resistance in the polycystic
ovary syndrome // Fertility and Sterility. 2005.
Vol. 83. P. 1454–1460.
22. Feldman S., Billaud l., Thalabard j. Fertility in
women with late onset adrenal hyperplasia due
to 21-hydroxylase deficiency // j Clin Endocrinol
metab. 1992. Vol. 74. P. 635–639.
23. Fruzzetti F. et al Treatment of hirsutism:
comparisons between different antiandrogens
with central and peripheral effects // Fértil. Steril.
2005. Vol. 71. P. 445–451.
24. Hahn S., Haselhorst u., Tan S. et al. low
serum 25-hydroxyvitamin D concentrations are
associated with insulin resistance and obesity
in women with polycystic ovary syndrome
// Experimental and Clinical Endocrinology and
Diabetes. 2006. Vol. 114. P. 577–583.
25. moret m., Stettler r., et. al. Insulin modulation of
luteinizing hormone secretion in normal female
volunteers and lean polycystic ovary syndrome
patients // neuroendocrinology. 2009. Vol. 89(2).
P. 131–139.
26. morin-Papunen l.C. Insulin sensitivity, insulin
secretion, and metabolic and hormonal parameters
in healthy women and women with polycystic
ovarian. new mI. Extensive clinical experience:
nonclassical 21-hydroxylase deficiency // Clin
Endocrinol metab. 2006. Vol. 91.
27. Pall m., azziz r., Beires j., Pignatelli D. The
phenotype of hirsute women: a comparison of
polycystic ovary syndrome and 21-hydroxylase-
deficient nonclassic adrenal hyperplasia // Fertil
Steril. 2010. Vol. 94(2). P. 684–689.
28. Pasquali r. androgens and obesity: fact and
perspectives // Fertil Steril. 2006. Vol. 85.
P. 1319–1340.
29. Sarici G., Cinar S., armutcu F. et al. Oxidative
stress in acne vulgaris // j Eur acad Dermatol
Venereol. 2010. Vol. 24(7). P. 763.
30. Sigrid E. Quality of life, psychosocial well-being,
and sexual satisfaction in women with PCOS
// j. of Clin. Endocrinol and metabolism. 2003.
Vol. 88. № 12. P. 801–809.
31. Sinclair r., Patel m., Dawson T.l. et.al. Hair loss
in women: medical and cosmetic approaches
to increase scalp hair fullness // Br j Dermatol.
2011. Vol. 165. Suppl 3. P. 8–12.
32. Slayden S.m. et al. Hyperandrogenemia in
patients presenting with acne // Fertility and
Sterility. 2005. Vol. 75. P. 889–892.
33. Svendsen P.F., madsbad S., nilas l. The insulin-
resistant phenotype of polycystic ovary syndrome
// Fertil Steril. 2010. Vol. 94 (3). P. 1052–1058.
34. Thiboutot D.m. acne and rosacea. new and
emerging therapies // Dermatol. Clin. 2006. Vol. 18.
P. 63–71.
35. Thiboutot D.m. Overview of acne and its
treatment // Cutis. 2008. Vol. 81. № 1. P. 3–7.
36. Thorneycroft I.H., Gollnick H., Schellschmidt I.
Superiority of a combined oral contraceptive
containing
drospirenone
to
a
triphasic
preparation containing norgestimate in acne
treatment // Cutis 2004. Vol. 74. P. 123-130.
37. Wehr E., Pilz S., Schweighofer n., Giuliani a.
et al. association of hypovitaminosis D with
metabolic disturbances in polycystic ovary
syndrome // European journal of Endocrinology.
2009. Vol. 161. P. 575–582.
38. yazici K. Disease-specific quality of life is
associated with anxiety and depression in
patients with acne // acad. Dermatol. Venerol.
2004. Vol. 18. P. 435–439.
39. yildizhan r., Kurdoglu m., adali E., et al.
Serum 25-hydroxyvitamin D concentrations in
obese and nonobese women with polycystic
ovary syndrome // archives of Gynecology and
Obstetrics. 2009. Vol. 280. P. 559–563.
Do'stlaringiz bilan baham: |
